An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP‐induced hyperaggregabiIity in streptozotocin‐induced diabetic rats
Authors:
- 1 December 1995
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 25 (12) , 948-954
Abstract
Rats with streptozotocin‐induced diabetes were oral given TAT, a potent aldose reductase inhibitor, at a dose of 10 rng kg‐1 day‐1or 40 mg kg‐1 day‐1 for 30 days. Prolongation of the peak latency of oscillatory potentials in the b‐wave of the electro‐retinogram (ERG), which is associated with retinal Müller cell dysfunction, was significantly improved by treatment with TAT as compared with untreated diabetic rats [Σ(O1+O2+ O3) was 106.8 ± 1.8 ms in normal controls (NC), 118.2 ±1. 1 ms in diabetic controls (DC) (P ‐1TAT (P< 0.001 vs. DC) and 111.4 ±1.6ms with 40 mg kg‐1 TAT (P<0.01 vs. DC)]. The improvement in ERG abnormalities in diabetic rats was accompanied by partial reduction of elevated sorbitol levels in the retina and erythro‐cytes, and by correction of platelet hyperaggregability. The authors' findings suggest that a better understanding of the mechanism by which TAT acts may provide new insights into the pathogenesis of hyper‐glycaemic retinal dysfunction and contribute to establishing effective therapy for diabetic retinopathy.Keywords
This publication has 40 references indexed in Scilit:
- Characterization of a Novel Aldose Reductase Inhibitor, TAT, and Its Effects on Streptozotocin-Induced Diabetic Neuropathy in RatsThe Japanese Journal of Pharmacology, 1993
- Effect of niceritrol on streptozocin-induced diabetic neuropathy in ratsDiabetes, 1992
- Current progress in clinical trials of aldose reductase inhibitors in JapanExperimental Eye Research, 1990
- Altered red and white blood cell rheology in type II diabetesDiabetes, 1986
- Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.Journal of Clinical Investigation, 1985
- Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and TherapyDiabetes Care, 1985
- Localization of aldose reductase in the human eyeDiabetes, 1984
- Effects of aging on the regenerative capacity of the pancreatic B-cell of the ratDiabetes, 1983
- Immunohistochemical localization of aldose reductase. II. Rat eye and kidneyDiabetes, 1980
- 2,3-DIPHOSPHOGLYCERATE AND TISSUE OXYGENATION IN UNCONTROLLED DIABETES MELLITUSThe Lancet, 1972